Abstract 5410: CDK9 pharmacological inhibition has antitumor activity in marginal zone lymphoma models and can improve the effects of BTK, PI3K, and BCL2 inhibitors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: Institute of Oncology Research, Ente Ospedaliero Cantonale
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409626805